Pharmaceuticals, Biotechnology and Life Sciences
KUALA LUMPUR, Malaysia, Jan. 19, 2026 (GLOBE NEWSWIRE) — CUKTECH has officially announced the launch of its flagship product, the…
Daridorexant is a dual orexin receptor antagonist being developed by Nxera for the treatment of adult patients with insomnia and…
CHAPEL-EN-LE-FRITH, United Kingdom, Jan. 19, 2026 (GLOBE NEWSWIRE) — Concept Life Sciences, a leading global contract research organization (CRO) specialising…
COPENHAGEN, Denmark, January 19, 2026 – Bavarian Nordic A/S (OMX: BAVA) announces transactions under the share buy-back program launched on…
Approval Label May Include Opioid ReductionNEW YORK, Jan. 18, 2026 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in…
Châtillon, France, January 16, 2026 DBV Technologies Announces €166.7 Million in Gross Proceeds Following the Full Exercise of the ABSA…
Etan Bendheim assumes role of CEO and Mark Warner moves to CTO role Liberation Bioindustries Announces New Roles for Founders…
HUNTSVILLE, Jan. 15, 2026 (GLOBE NEWSWIRE) — Serina Therapeutics, Inc. (“Serina” or the “Company”) (NYSE American: SER), a clinical-stage biotechnology company…
All resolutions passed, enabling the Company to streamline regulatory and operational processesSAN DIEGO, Jan. 15, 2026 (GLOBE NEWSWIRE) — Oncolytics…
New York City, NY, Jan. 15, 2026 (GLOBE NEWSWIRE) — As metabolism supplements continue to grow in popularity in 2026,…